Thomas Kent

Currently holds a position at Tekla Life Sciences Investors

Position	Company	Period
Independent Trustee	Tekla Life Sciences Investors	Jan. 1, 2017 -

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2018-01-29	2018-01-25	Tekla Healthcare Investors (HQH)	B Purchase	1,100 +inf% 24.19 USD 26,605	1,100 +inf%	24.19	USD 26,605
2018-01-29	2018-01-25	Tekla Healthcare Opportunities Fund (THQ)	B Purchase	1,400 +inf% 18.50 USD 25,903	1,400 +inf%	18.50	USD 25,903
2018-01-29	2018-01-25	Tekla Life Sciences Investors (HQL)	B Purchase	1,300 +inf% 21.04 USD 27,348	1,300 +inf%	21.04	USD 27,348
2018-01-29	2018-01-25	Tekla World Healthcare Fund (THW)	B Purchase	1,800 +inf% 14.52 USD 26,128	1,800 +inf%	14.52	USD 26,128